Interview with Ali Akyildiz, General Manager, IMS Health Turkey
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS…
IMS started to operate in Turkey through some other local companies in the late 60s. The first report was published in 1968. Since the inception of the local entity in 1990, it has grown significantly serving both local and multinational clients by providing information, technology solutions and professional services including consulting. Our information panel covers over 99% of the market in terms of pharmaceutical sales data and accepted as a gold standard in the industry. Our consulting team consists of 20 professional consultants and acting as a hub for Middle East to support our clients in solving their problems in portfolio strategy, market entry, mergers & acquisitions and commercial effectiveness.
Currently, IMS Turkey is serving more than 150 clients in these areas with about 140 professionals with our recent Cegedim acquisition.
Contact Details
Gazeteciler Mahallesi
Yazarlar Sokak – No. 8, 34394 Esentepe – Sisli
Istanbul
Turkey
Tel: +90 212 355 57 00
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish pharma industry moving towards biotechnology. Moreover, they give insights into Ekin Kimya’s partnership strategy…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish market. She provides her expert insights into current trends in the Turkish generics…
Uğur Bingöl, general manager of Ibrahim Etem Menarini, speaks of his company’s rapid growth and new product lines. He also describes his take on the Turkish pharmaceutical market and outlines…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares the company’s plans to become Turkey’s leading biotech entity and gives insights into the group’s international expansion plans. He…
The Minister of Health of the Republic of Turkey, Dr Fahrettin Koca, provides an overview of the current state of the Turkish healthcare ecosystem, highlighting its opportunities and challenges. He…
Handan Boyce, general manager of the Istanbul Lütfi Kırdar International Convention and Exhibition Center, offers her insights into the Turkish congress sector, underlining the industry’s strong suits and highlighting the…
Levent Canyurt, CEO and founder of BIEM Ilac, shares how he transformed the company from a domestic pharmaceutical distributor into an international player, with an innovative portfolio for the treatment…
Mehmet Baharoglu and Beril Tezcanli of Birgi Mefar Group, Turkey’s leading CMO with a proven track record and experience of production across all small and medium volume injectable dosage forms…
* Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland…
Barış Özyurtlu, general manager of Berko Pharmaceuticals, one of the fastest growing companies in Turkey, provides insights into the company’s innovative vision and proprietary technologies, such as its spoon-shaped product…
Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the ICVB’s services, the main trends shaping the city’s…
Mahmut Oguzcan, country business leader of 3M Turkey, offers his expert insights into the Turkish medical devices market. He explains how Turkey’s Health Transformation Program (HTP) and private-public partnership (PPP)…
See our Cookie Privacy Policy Here